Allergy
EpiPen supply issues to continue indefinitely
While Pfizer is working to achieve ongoing availability, it reportedly cannot commit to a specific time when the supply constraint will be fully resolved Mylan/Alphapharm, the sponsor of EpiPens, has …
Hay fever not taken seriously
A fifth of hay fever sufferers have taken time off work because of their condition… but they’re afraid to be honest about it with the boss UK media report that …
Little role for sedating antihistamines: Experts
Newer, less sedating forms can be safely taken long term with no loss of efficacy, according to latest evidence In a new article for Australian Prescriber, immunology experts have concluded …
Clinical tips: anaphylaxis
Louis Roller takes a look at the most serious form of allergic reaction: anaphylaxis Anaphylaxis is the most severe form of allergic reaction and is potentially life threatening. It must …
Research Roundup
Debbie Rigby takes a look at the latest in research news Deprescribing antihyperglycemic agents in older persons This guideline provides practical recommendations for making decisions about deprescribing antihyperglycemic agents. Deprescribing …
Updated handbook includes thunderstorm asthma advice
The National Asthma Council has released version 1.3 of the Australian Asthma Handbook This revision includes important and timely guidance on treatment implementations of thunderstorm asthma, managing allergic rhinitis in …
Oral anthistamines do play a role: ASMI
The Australian Self Medication Industry is urging consumers with hayfever to discuss their symptoms with their doctor or pharmacist so that they receive the most appropriate treatment plan This statement …
Use INCS alone, not with antihistamine tablets: experts
A nasal spray alone may be more beneficial than adding an antihistamine tablet when treating hayfever, US experts suggest The Joint Task Force on Practice Parameters, which comprises representatives of …
Mylan offers free short-expiry EpiPens during shortage
EpiPen Jr is likely to be back in stock by mid-November, Mylan has advised In the meantime, Mylan has announced that it will supply eligible patients an EpiPen Jr 150mcg …
The peak time for asthma
Act now to help your patients with asthma navigate allergy season, writes Stephenie Shea Asthma is a common chronic condition of the airways, where one in nine Australians are affected—that’s …
Clinical tips: seasonal allergic rhinitis
Pharmacists can help clear up a lot of the myths around hayfever, writes Jarrod McMaugh Seasonal rhinitis may well be considered a pharmacist’s “bread and butter” – from the peaks …
‘Hard proof’ of asthma reliever over-reliance
Nearly 40% of people with asthma only use reliever medicines, new research has found A study led by Woolcock Institute of Medical Research in Sydney found that 39% of almost …